|
1
|
Wu X, Gu J, Wu TT, et al: Genetic
variations in radiation and chemotherapy drug action pathways
predict clinical outcomes in esophageal cancer. J Clin Oncol.
24:3789–3798. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mader RM, Schmidt WM, Steger GG and
Krupitza G: Molecular mechanisms of drug resistance. Int J Clin
Pharmacol Ther. 47:49–50. 2009. View
Article : Google Scholar
|
|
3
|
Wen J, Zheng B, Hu Y, et al: Establishment
and biological analysis of the EC109/CDDP multidrug-resistant
esophageal squamous cell carcinoma cell line. Oncol Rep. 22:65–71.
2009.PubMed/NCBI
|
|
4
|
Choi HS, Kim HS, Min KR, et al:
Anti-inflammatory effects of fangchinoline and tetrandrine. J
Ethnopharmacol. 69:173–179. 2000. View Article : Google Scholar
|
|
5
|
Koh SB, Ban JY, Lee BY and Seong YH:
Protective effects of fangchinoline and tetrandrine on hydrogen
peroxide-induced oxidative neuronal cell damage in cultured rat
cerebellar granule cells. Planta Med. 69:506–512. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gong X, Luo FL, Zhang L, et al:
Tetrandrine attenuates lipopolysaccharide-induced fulminant hepatic
failure in D-galactosamine-sensitized mice. Int Immunopharmacol.
10:357–363. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu JM, Chen Y, Chen JC, Lin TY and Tseng
SH: Tetrandrine induces apoptosis and growth suppression of colon
cancer cells in mice. Cancer Lett. 287:187–195. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li X, Su B, Liu R, Wu D and He D:
Tetrandrine induces apoptosis and triggers caspase cascade in human
bladder cancer cells. J Surg Res. 166:e45–e51. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao QX, Chen BA, Cheng J, et al: Effect
of tetrandrine, toremifene and their combination on the reversion
of multidrug resistance of K562/A02 cell line. Zhongguo Shi Yan Xue
Ye Xue Za Zhi. 16:61–64. 2008.(In Chinese).
|
|
10
|
Zhang H, Gao A, Li F, Zhang G, Ho HI and
Liao W: Mechanism of action of tetrandrine, a natural inhibitor of
Candida albicans drug efflux pumps. Yakugaku Zasshi.
129:623–630. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Koh HL, Wang H, Zhou S, Chan E and Woo SO:
Detection of aristolochic acid I, tetrandrine and fangchinoline in
medicinal plants by high performance liquid chromatography and
liquid chromatography/mass spectrometry. J Pharm Biomed Anal.
40:653–661. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Roelofsen H, Vos TA, Schippers IJ, et al:
Increased levels of the multidrug resistance protein in lateral
membranes of proliferating hepatocyte-derived cells.
Gastroenterology. 112:511–521. 1997. View Article : Google Scholar
|
|
13
|
Bakos E and Homolya L: Portrait of
multifaceted transporter, the multidrug resistance-associated
protein 1 (MRP1/ABCC1). Pflugers Arch. 453:621–641. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He SM, Li R, Kanwar JR and Zhou SF:
Structural and functional properties of human multidrug resistance
protein 1 (MRP1/ABCC1). Curr Med Chem. 18:439–481. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Abaan OD, Mutlu PK, Baran Y, Atalay C and
Gunduz U: Multidrug resistance mediated by MRP1 gene overexpression
in breast cancer patients. Cancer Invest. 27:201–205. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kweon SH, Song JH and Kim TS:
Resveratrol-mediated reversal of doxorubicin resistance in acute
myeloid leukemia cells via downregulation of MRP1 expression.
Biochem Biophys Res Commun. 395:104–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
EI-Sharnouby JA, Abou EI-Enein AM, EI
Ghannam DM, et al: Expression of lung resistance protein and
multidrug resistance-related protein (MRP1) in pediatric acute
lymphoblastic leukemia. J Oncol Pharm Pract. 16:179–188. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
DeGorter MK, Conseil G, Deeley RG,
Campbell RL and Cole SP: Molecular modeling of the human multidrug
resistance protein 1 (MRP1/ABCC1). Biochem Biophys Res Commun.
365:29–34. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Munoz M, Henderson M, Haber M and Norris
M: Role of the MRP1/ABCC1 multidrug transporter protein in cancer.
IUBMB Life. 59:752–757. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Payen L, Delugin L, Courtois A, Trinquart
Y, Guillouzo A and Fardel O: The sulphonylurea glibenclamide
inhibits multidrug resistance protein (MRP1) activity in human lung
cancer cells. Br J Pharmacol. 132:778–784. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wesolowska O, Wisniewski J, Sroda K, et
al: 8-Prenylnaringenin is an inhibitor of multidrug
resistance-associated transporters, P-glycoprotein and MRP1. Eur J
Pharmacol. 644:32–40. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang W, Sun YP, Huang XZ, et al: Emodin
enhances sensitivity of gallbladder cancer cells to platinum drugs
via glutathion depletion and MRP1 downregulation. Biochem
Pharmacol. 79:1134–1140. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nooter K, Kok T, Bosman FT, van Wingerden
KE and Stoter G: Expression of the multidrug resistance protein
(MRP) in squamous cell carcinoma of the oesophagus and response to
pre-operative chemotherapy. Eur J Cancer. 34:81–86. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Murase M, Kodera Y, Kondo K, et al:
Expression of MRP and mdr1 in human gastrointestinal cancer cell
lines: a correlation with resistance against doxorubicin. J Surg
Oncol. 61:223–229. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Langer R, Ott K, Feith M, et al: High
pretherapeutic thymidylate synthetase and MRP-1 protein levels are
associated with nonresponse to neoadjuvant chemotherapy in
oesophageal adenocarcinoma patients. J Surg Oncol. 102:503–508.
2010. View Article : Google Scholar
|
|
26
|
Takebayashi Y, Akiyama S, Natsugoe S, et
al: The expression of multidrug resistance protein in human
gastrointestinal tract carcinomas. Cancer. 82:661–666. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen BA, Guo JJ and Cheng J: Biomolecular
mechanisms of cyclosporine A, tetrandrine and their combination on
the reversion of multidrug resistance in human leukemia cell line.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 28:1010–1013. 2008.(In
Chinese).
|
|
28
|
Xu WL, Shen HL, Ao ZF, et al: Combination
of tetrandrine as a potential-reversing agent with daunorubicin,
etoposide and cytarabine for the treatment of refractory and
relapsed acute myelogenous leukemia. Leuk Res. 30:407–413. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fu L, Liang Y, Deng L, et al:
Characterization of tetrandrine, a potent inhibitor of
P-glycoprotein-mediated multidrug resistance. Cancer Chemother
Pharmacol. 53:349–356. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu ZL, Hirano T, Tanaka S, Onda K and Oka
K: Persistent reversal of P-glycoprotein-mediated daunorubicin
resistance by tetrandrine in multidrug-resistant human T
lymphoblastoid leukemia MOLT-4 cells. J Pharm Pharmacol.
55:1531–1537. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wei N, Sun H, Wang F and Liu G: H1, a
novel derivative of tetrandrine reverse P-glycoprotein-mediated
multidrug resistance by inhibiting transport function and
expression of P-glycoprotein. Cancer Chemother Pharmacol.
67:1017–1025. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen LM, Liang YJ, Zhang X, et al:
Reversal of P-gp-mediated multidrug resistance by Bromotetrandrine
in vivo is associated with enhanced accumulation of
chemotherapeutical drug in tumor tissue. Anticancer Res.
29:4597–4604. 2009.PubMed/NCBI
|
|
33
|
Wang TX and Yang XH: Reversal effect of
isotetrandrine, an isoquinoline alkaloid extracted from Caulis
Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in
human breast cancer (MCF-7/DOX) cells. Yao Xue Xue Bao. 43:461–466.
2008.PubMed/NCBI
|
|
34
|
Li GH, Liu MX, Sun FJ, et al: The effect
of tetrandrine on the expression of the P170, LRP and TOPO II in
S180’s tumor cell induced by chemotherapy in the mice with acquired
multi-drug resistance. Zhongguo Zhong Yao Za Zhi. 30:1280–1282.
2005.(In Chinese).
|
|
35
|
Chen BA, Su AL, Cheng J, Zhao HH, Li GH
and Wang XM: Effects of tetrandrine on nuclear factor-kappaB
expression in leukemia multidrug-resistant cell line K562/A02.
Zhong Xi Yi Jie He Xue Bao. 6:956–959. 2008.(In Chinese).
|
